All RCUS Content

Arcus Biosciences, Inc (RCUS) Arcus Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides a Pipeline Update

Arcus Biosciences, Inc (NYSE: RCUS) Q4 2025 Earnings Release

February 25, 20261 min read

Arcus Biosciences, Inc (RCUS) Arcus Presents New Data for its HIF-2a Inhibitor Casdatifan, Which Showed Progression-Free Survival Beyond One Year in Late-Line Kidney Cancer

Arcus Biosciences, Inc (NYSE: RCUS) FY 2026 Other Release

February 23, 20261 min read

Arcus Biosciences, Inc (RCUS) Q4 2025 Earnings Call

Arcus Biosciences, Inc (NYSE: RCUS) Q4 2025 Earnings Conference

February 11, 20261 min read

Arcus Biosciences, inc (RCUS) Arcus Biosciences to Report Second Quarter 2021 Financial Results & Recent Corporate Highlights

Arcus Biosciences, inc (NYSE: RCUS) Q2 2021 Earnings Conference

August 9, 20211 min read